Sentences with phrase «influenza vaccines»

As it does with all influenza vaccines, the FDA will evaluate Flublok annually prior to use by the public each flu season.

The most commonly reported adverse events included pain at the site of injection, headache, fatigue and muscle aches, events also typical for conventional egg - based, inactivated influenza vaccines.

Flublok's novel manufacturing technology allows for production of large quantities of the influenza virus protein, hemagglutinin (HA)-- the active ingredient in all inactivated influenza vaccines that is essential for entry of the virus into cells in the body.

In recent months I have received a greater number of scope - of - practice questions about limited scope radio - graphy, telephone screening (following physician - approved protocols, algorithms, or decision trees), and administration of influenza vaccines, for example.

The nonsignificant adjusted VE of 9 % against A (H3N2) among persons aged ≥ 65 years is similar to the estimate in a recent interim report from Europe (6) and reinforces the need for continued advances in influenza vaccines, especially to increase protective benefits for older adults.»

Another patent, 2007024947 / WO - A 2, assigned to Merial, also discusses canine influenza vaccines.

Fluvac Innovator ® vaccines are the most trusted equine influenza vaccines and help provide your horse with broad protection against newly emerging and conventional equine influenza virus strains as well as equine herpesvirus (EHV 1 and EHV 4).4 - 10 Zoetis regularly tests Fluvac Innovator to ensure its vaccine continues to be effective against emerging EIV isolates.

VCF also offers Lepto, bordetella, lyme and canine influenza vaccines for dogs.

Like other dog influenza vaccines, it may not prevent infection of the dog, but will reduce the severity of the clinical disease, it will reduce the progression of the disease to pneumonia, and reduce the time that a dog can spread the disease to other dogs.

There are three dog influenza vaccines.

Canine influenza vaccines can reduce the risk of disease and are available from veterinarians in Canada.

At North Elm, we have influenza vaccines available but are not currently recommending vaccinating every dog.

Ask your veterinarian if she recommends one of the canine influenza vaccines.

The first vaccine for canine influenza virus H3N8 was approved in 2009, and there are several H3N8 canine influenza vaccines available.

Live attenuated influenza vaccines have been shown to provide better immune responses to protect against influenza.

To date, only CIV inactivated influenza vaccines (i.e. made of killed virus) are available commercially.

A: The first canine vaccine for H3N8 canine influenza was approved in 2009, and there are several H3N8 canine influenza vaccines available.

Non-structural protein 1 (NS1) truncated (NS1 - 126, NS1 - 99 and NS1 - 73) or deleted (DNS1) H3N8 canine influenza viruses (CIVs) were tested for their safety, immunogenicity and protection efficacy as live - attenuated influenza vaccines (LAIVs) against wild - type (WT) H3N8 CIV.

The researchers themselves even recognize the link between vaccines and disease, saying that «Cases of GBS after rabies and swine influenza vaccines also have been reported.»

At this time, the two available canine influenza vaccines cover H3N2 and H3N8.

There are canine influenza vaccines available for use in dogs only.

A: The first vaccine for H3N8 canine influenza was approved in 2009, and there are several H3N8 canine influenza vaccines available.

Several related anecdotes about and experiences with Merck Animal Health, maker of one of two canine influenza vaccines on the market, pressing boarding kennels and shelters to require or administer the vaccine routinely.

Required Vaccines and tests for boarding with us are: Dogs - Negative fecal on file within 6 months, Rabies, Bordetella vaccine, Distemper Parvo vaccine, both strains of the Influenza vaccines (H3N2, H3N8) negative Heartworm test within the last year and must be on Heartworm and Flea preventative.

Like the multidose influenza vaccines, some multidose meningococcal meningitis vaccines and tetanus toxoid (booster) vaccines (not recommended for children under six years of age) also contain thimerosal as a preservative, in amounts ranging from 12.5 to 25 micrograms per dose.27, 28 As of 2016, some other childhood vaccine preparations, such as the multidose DTaP and the DTaP / Hib combination vaccines, still utilize thimerosal in the manufacturing process.

Influenza vaccines are Category B or C drugs, which means that adequate and well - controlled studies on pregnant women have not been conducted and it is not known whether these vaccines can cause fetal harm when administered to a pregnant woman or if they can affect reproduction capacity.

A modeling - based comparison of broad - spectrum influenza vaccines against conventional, strain - matched vaccines» by Rahul Subramanian et al. published in PLOS Computational Biology on Thursday 15 December 2016.

Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and lessen the...

Breakthrough strategies to improve the current influenza vaccines are required to avoid a crisis in health care.

The other two pandemic influenza projects focus on the efficacy of recombinant protein and VLP pandemic influenza vaccines combined with IDRI's adjuvant technology.

«This is an interesting theoretical paper using mathematical modelling to predict the possible effects of influenza vaccines that have not yet been developed on the circulation and evolution of flu viruses.

«So, this is an interesting but theoretical analysis based on speculation on what future influenza vaccines might do.

Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection...

Several candidate gene studies suggest that variations in HLA class 1 and other genes contribute to differences in antibody response to influenza vaccines [15], [69], [70].

In clinical trials, several candidate H7N9 pandemic influenza vaccines made from inactivated viruses have been shown to be safe and to generate an immune response.

«Influenza vaccines have been in use for over 50 years, but there are very few studies that have been able to follow the same people for a long period of time particularly in such a well documented group of vaccinees.»

The study also suggests ways to make influenza vaccines even safer, for instance by keeping the nucleoprotein levels low or removing the specific region of the protein that mimics the receptor.

The study «tackles a question that is of great pragmatic importance for vaccines,» says virologist Gary Nabel in Cambridge, Massachusetts, who is the chief scientific officer at Sanofi, which makes influenza vaccines.

(Two U.S. influenza vaccines do not use egg - adapted strains.

Influenza vaccines have been developed to prevent the yearly outbreaks of this respiratory illness and to protect people at risk from developing severe disease.

In contrast to many other vaccines, influenza vaccines need to be reformulated each year because circulating influenza viruses continuously evolve.

«This younger population should be targeted for the use of the quadrivalent influenza vaccines.»

Commonly administered influenza vaccines are generally composed of two influenza A lineage viruses — but only one influenza B lineage virus.

Thiomersal is also added to influenza vaccines, which can be important in developed countries.

A group from the NIH's National Institute of Allergy and Infectious Diseases (NIAID) evaluated the live imaging system as a potential alternative to traditional methods of assessing investigative influenza vaccines and treatment in mice, which can be time consuming and require more study animals for valid statistical comparison.

«From a pandemic - preparedness point of view, we should potentially start including some of these H3 strains as part of influenza vaccines.»

«The idea behind this study was to re-evaluate the bar that was previously established for evaluating a person's immune response to influenza vaccines,» said the study's principal investigator Matthew J. Memoli, M.D., director of the Clinical Studies Unit in NIAID's Laboratory of Infectious Diseases.

The H3N2 strain is one of three in the seasonal influenza vaccines.

Phages would require a less traditional approach to get official approval, such as the annual process for influenza vaccines in which manufacturers secure approval of new formulas based on the flu bug that is going around that year, instead of conducting big clinical trials every time.

Currently, most influenza vaccines in the United States are produced using chicken eggs, while a few are made in cell culture or by using recombinant DNA technologies.